Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Large-scale testing (Phase 3)Temporarily pausedNCT00002362
What this trial is testing

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Not applicableStudy completedNCT00002142
What this trial is testing

An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Gilead Sciences 100
Large-scale testing (Phase 3)Study completedNCT00002416
What this trial is testing

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 390
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Testing effectiveness (Phase 2)Study completedNCT00002162
What this trial is testing

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 140
Large-scale testing (Phase 3)Study completedNCT02369965
What this trial is testing

Test Albuvirtide in Experienced Patients

Who this might be right for
HIV InfectionsAIDS
Frontier Biotechnologies Inc. 418
Testing effectiveness (Phase 2)Study completedNCT00120367
What this trial is testing

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Who this might be right for
Leukoencephalopathy, Progressive MultifocalHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 30
Post-approval studies (Phase 4)Ended earlyNCT00356616
What this trial is testing

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 24
Early research (Phase 1)Looking for participantsNCT07698600
What this trial is testing

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 126
Not applicableStudy completedNCT00002081
What this trial is testing

Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease

Who this might be right for
HIV Infections
Hoffmann-La Roche
Early research (Phase 1)Study completedNCT00001009
What this trial is testing

Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Study completedNCT04050371
What this trial is testing

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy

Who this might be right for
HIV PreventionTransgender Health
University of California, San Francisco 48
Post-approval studies (Phase 4)Study completedNCT00002179
What this trial is testing

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 200
Testing effectiveness (Phase 2)Study completedNCT06719310
What this trial is testing

Phase Ib/IIa Clinical Study of ACC017 Tablets

Who this might be right for
Infection, Human Immunodeficiency Virus
Jiangsu Aidea Pharmaceutical Group Co., Ltd. 36
Not applicableStudy completedNCT00002205
What this trial is testing

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Testing effectiveness (Phase 2)Study completedNCT00002110
What this trial is testing

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

Who this might be right for
HIV Infections
Mylan Laboratories 300
Next Page